Innate Pharma S.A.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
The company wire is refreshing.
No verified current item is available. Search remains available while sources reconnect.
Search IPHA →Latest IPHA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
6-KOfficial SEC filingFiled 2026-07-23 · Period 2026-07-23SEC ↗6-KOfficial SEC filingFiled 2026-07-21 · Period 2026-07-21SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-06-22SEC ↗6-KOfficial SEC filingFiled 2026-05-22 · Period 2026-05-22SEC ↗6-KOfficial SEC filingFiled 2026-05-19 · Period 2026-05-19SEC ↗6-KOfficial SEC filingFiled 2026-05-13 · Period 2026-05-13SEC ↗6-KOfficial SEC filingFiled 2026-05-12 · Period 2026-05-12SEC ↗6-KOfficial SEC filingFiled 2026-05-06 · Period 2026-05-06SEC ↗
Innate Pharma S.A., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →